Phase 4 COPD Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults who carry one copy of a specific genetic variant called the SERPINA1 Z allele (a gene change linked to a condition called Alpha-1 Antitrypsin Deficiency)
- People who have either had no serious flare-ups of a chronic lung condition (COPD) in the past year, or who have had 2 or more serious flare-ups in the past year
- People who have not received a pneumococcal conjugate vaccine (a specific type of pneumonia vaccine) in the last 5 years, or who have only ever received a different type of pneumonia vaccine called the pneumococcal polysaccharide vaccine
Who may not be able to join:
- People who have received a pneumococcal conjugate vaccine within the past 5 years
- People who have a known allergy, serious reaction, or sensitivity to pneumococcal conjugate vaccines (a specific type of pneumonia vaccine)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 2059343411
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Antibody response
Can't join this trial?
Data last synced from ClinicalTrials.gov: 12 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.